Dr Michael Nasr Mankarious, MD | |
638 S Bluff Blvd, Clinton, IA 52732-4742 | |
(563) 243-5601 | |
(563) 243-5637 |
Full Name | Dr Michael Nasr Mankarious |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 45 Years |
Location | 638 S Bluff Blvd, Clinton, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659375921 | NPI | - | NPPES |
53222 | Other | IA | BLUE CROSS |
110076724 | Other | IA | RR MEDICARE |
2089383 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 28726 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercyone Clinton Home Care & Hospice | Clinton, IA | Home health agency |
Mercy Home Care And Hospice | Clinton, IA | Hospice |
Mercyone Clinton Medical Center | Clinton, IA | Hospital |
Genesis Medical Center-davenport | Davenport, IA | Hospital |
The Alverno Senior Care Community | Clinton, IA | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mercy Specialty Clinic | 3375639586 | 59 |
News Archive
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, recently published a commentary in the American Journal of Medicine, about the benefits of statins in the prevention of heart attacks and strokes in subjects previously thought at too low a risk to be treated.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
Humana Inc. has released seven new videos in its popular "Stay Smart, Stay Healthy" series. These videos – designed to help health care consumers better understand how health insurance works, and what factors affect the costs they pay – are now available on YouTube and at www.StaySmartStayHealthy.com.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
› Verified 7 days ago
Entity Name | Mercy Specialty Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386832764 PECOS PAC ID: 3375639586 Enrollment ID: O20071019000139 |
News Archive
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, recently published a commentary in the American Journal of Medicine, about the benefits of statins in the prevention of heart attacks and strokes in subjects previously thought at too low a risk to be treated.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
Humana Inc. has released seven new videos in its popular "Stay Smart, Stay Healthy" series. These videos – designed to help health care consumers better understand how health insurance works, and what factors affect the costs they pay – are now available on YouTube and at www.StaySmartStayHealthy.com.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael Nasr Mankarious, MD 621 S Illinois Ave, Suite 103, Mason City, IA 50401-5405 Ph: (641) 428-3041 | Dr Michael Nasr Mankarious, MD 638 S Bluff Blvd, Clinton, IA 52732-4742 Ph: (563) 243-5601 |
News Archive
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, recently published a commentary in the American Journal of Medicine, about the benefits of statins in the prevention of heart attacks and strokes in subjects previously thought at too low a risk to be treated.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
Humana Inc. has released seven new videos in its popular "Stay Smart, Stay Healthy" series. These videos – designed to help health care consumers better understand how health insurance works, and what factors affect the costs they pay – are now available on YouTube and at www.StaySmartStayHealthy.com.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
› Verified 7 days ago
Dr. Suheil I Barakat, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 13th Ave N, Clinton, IA 52732 Phone: 563-243-2511 Fax: 563-243-0817 | |
Dr. Ahmed Fathala, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2745 Lincoln Way, Clinton, IA 52732 Phone: 563-242-3208 Fax: 563-242-4051 | |
Dr. Saadi J Albaghdadi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 13th Ave N, Clinton, IA 52732 Phone: 563-243-2511 Fax: 563-243-0817 | |
Humaira K Naseer, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 915 13th Ave N, Clinton, IA 52732 Phone: 563-243-2511 Fax: 563-243-0817 | |
Dr. Anwer Rasheed, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 13th Ave N, Clinton, IA 52732 Phone: 563-243-2511 Fax: 563-243-0817 | |
Dr. Ahmed Elahmady, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2745 Lincoln Way, Clinton, IA 52732 Phone: 563-242-3208 Fax: 563-242-4051 | |
Dr. Qaiser Rasheed, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 13th Ave N, Clinton, IA 52732 Phone: 563-243-2511 Fax: 563-243-0817 |